Eventually, a lot of GLP-1 compounding won\u2019t be necessary, as patients will have access to FDA-approved injections. Whether that\u2019s weeks away or months (or years) down the road, if you\u2019ve made GLP-1s a significant part of your practice, you need to think about the future.\u00a0<\/p>\n
Join us at the Owner Summit for a panel discussion and Q&A on this very topic, featuring Shawn Hodges, Rob Kilgore, and Ndidiamaka Okpareke of Revelation Pharma. Don\u2019t guess about the future \u2014 brainstorm with the experts so you\u2019re prepared for whatever comes next.<\/p>\n
(And don\u2019t forget the 2nd Annual OneFund Golf Tournament Fundraiser at Baytowne Golf Club on Friday, March 14, in conjunction with the Owner Summit. The $500\/person fee includes a contribution to OneFund, which helps pay for APC\u2019s critical advocacy apparatus: lobbying, research, outreach, marketing, and coalition-building with sister organizations.)<\/p>\n","protected":false},"excerpt":{"rendered":"